Rocket Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Progress

Go back to Rocket Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Progress
(NASDAQ: RCKT) Delayed: 2.31 +0.11 (5.00%)
Previous Close $2.20    52 Week High $ 
Open $2.20    52 Week Low $ 
Day High $2.34    P/E N/A 
Day Low $2.18    EPS $ 
Volume 2,163,543